Molecular Characterization of Canine Parvovirus in Iran, 2023
Archives of Razi Institute · 2026
DOI: 10.66224/ari.81.1.3354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Razi Institute, 2026. Verfasst von Zahra Ziafati Kafi und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Canine parvo virus 2 causes severe and often fatal gastroenteritis and myocarditis in dogs and puppies. Based on the VP2 gene, this virus is classified into 3 variants: CPV-2a, CPV-2b, and CPV-2c. Materials & Methods: In present study, 35 rectal swab samples were collected from dogs with clinical signs, including vomiting and diarrhea, and cases with positive results from the rapid test kit. Samples were screened with polymerase chain reaction (PCR) assay to detect the presence of the virus genome. According to the PCR results, all samples were positive.
Results
Out of 35 cases, about 34% received at least one dose of vaccine, and almost 66% were not vaccinated at all. A rapid test was also performed for 34 cases; it was positive for 91% (31 cases) and negative for 9% (3 cases). Phylogenetic analysis of seven samples, which were submitted for sequencing, revealed that 6 of the present isolates (UT-CPV14 to UT-CPV18 and UT-CPV20) were clustered with CPV-2c isolates, and one (UT-CPV19) was clustered with CPV-2b sequences. Homology analysis indicated high similarity (100%) between isolates (UT-CPV14 to UT-CPV18 and UT-CPV20) and isolates K20172c-1, 12B, IZSSI_2021PA43108idAki, BJ001, and CPV-2c/Sull6/2017. UT-CPV19 showed 100% similarity with isolates 19R113-2, YANJI-2, and 15D184. In the present study, we also phylogenetically analyzed a commercial vaccine. Although the homology results indicated almost 98% similarity between the current isolates and the vaccine, the vaccine sequence did not cluster with any groups in the phylogenetic tree.
Conclusion
These results highlight the importance of constantly monitoring antigenic changes of circulating strains and the efficacy of vaccines against them.
Zitieren
APA
Kafi, Z. Z., Sarmadi, S., Babazadeh, S., Jamiri, F., Bakhshi, A., Abbassioun, A., Eghbali, O., & Ghalyanchilangeroudi, A. (2026). Molecular Characterization of Canine Parvovirus in Iran, 2023. Archives of Razi Institute. https://doi.org/10.66224/ari.81.1.3354
Vancouver
Kafi ZZ, Sarmadi S, Babazadeh S, Jamiri F, Bakhshi A, Abbassioun A, et al. Molecular Characterization of Canine Parvovirus in Iran, 2023. Archives of Razi Institute. 2026. doi:10.66224/ari.81.1.3354
BibTeX
@article{Kafi2026,
author = {Kafi, Zahra Ziafati and Sarmadi, Soroush and Babazadeh, Shabnam and Jamiri, Fahimeh and Bakhshi, Alireza and Abbassioun, Aryan and Eghbali, Omid and Ghalyanchilangeroudi, Arash},
title = {Molecular Characterization of Canine Parvovirus in Iran, 2023},
journal = {Archives of Razi Institute},
year = {2026},
doi = {10.66224/ari.81.1.3354}
}
EUVIMED